Jazz Pharmaceuticals plc 4

EVP and Chief Commercial Officer Samantha Pearce had 2,527 Jazz Pharmaceuticals ordinary shares withheld for taxes upon RSU vesting, leaving her with 47,911 shares owned directly.

On June 30, 2026, Samantha Pearce, EVP and Chief Commercial Officer of Jazz Pharmaceuticals plc, had 2,527 ordinary shares withheld by the company at an implied price of $237.72 per share (about $600,000 in value) to satisfy tax obligations arising from the vesting of previously granted restricted stock units, a non-discretionary, compensation-related transaction that left her with 47,911 ordinary shares owned directly. A footnote also discloses that she acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 29, 2026, but this plan-based purchase is not itemized as a separate line transaction in the excerpted table.

Filing Facts

CIK

1232524

Ticker

JAZZ

Form

4

Source Type

sec

Accession

0001805688-26-000012

Alert Tier

5